apprehend < approach < approaches

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]

Ident.	Authors (with country if any)	Title
000000 (2009)	Susan P. Bruce [États-Unis]	Recent Developments in the Treatment of Rheumatoid Arthritis
000022 (2011)	Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]	Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000025 (2014)	Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]	Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
000047 (2012)	N. Schütz [Allemagne] ; E. M Rker-Hermann [Allemagne]	Rheumatoide Arthritis und multiples Myelom als Komorbidität
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000071 (2010)	A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]	Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000072 (2014)	Sabeeda Kadavath [États-Unis] ; Ekaterini Zapantis [États-Unis] ; Ronald Zolty [États-Unis] ; Petros Efthimiou [États-Unis]	A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult‐onset Still's disease: targeting IL‐6
000088 (2011)	Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]	Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000169 (2015)	Yanli Zhuang [États-Unis] ; Dick E. De Vries [Pays-Bas] ; Zhenhua Xu [États-Unis] ; Stanley J. Marciniak Jr. [États-Unis] ; Dion Chen [États-Unis] ; Francisco Leon [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis]	Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000181 (2015)	Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]	Challenges and considerations for development of therapeutic proteins in pediatric patients
000193 (2012)	L. K. King ; A. Lee [Australie] ; A. Anandacoomarasamy [Australie]	Use of biological disease‐modifying anti‐rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B
000210 (2013)	K K Machavaram [Royaume-Uni] ; L M Almond [Royaume-Uni] ; A. Rostami-Hodjegan [Royaume-Uni] ; I. Gardner [Royaume-Uni] ; M. Jamei [Royaume-Uni] ; S. Tay [États-Unis] ; S. Wong [États-Unis] ; A. Joshi [États-Unis] ; J R Kenny [États-Unis]	A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL‐6
000227 (2006)	Marcus D. Köller [Autriche]	Targeted therapy in rheumatoid arthritis
000241 (2010)	Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]	Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000249 (2010)	R. E. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne]	Biologika in Schwangerschaft und Stillzeit
000280 (2010)	Valeria Bruno [Italie] ; Giuseppe Battaglia [Italie] ; Ferdinando Nicoletti [Italie]	The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases
000300 (2012)	Joerg-Patrick Stübgen [États-Unis]	Targeted immunotherapy trials for idiopathic inflammatory myopathies
000322 (2007)	M. Feuchtenberger [Allemagne] ; C. Kneitz [Allemagne] ; H.-P. Tony [Allemagne]	Zytokine
000364 (2013)	N. Stein [Allemagne] ; M. Witt [Allemagne] ; M. Baeuerle [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Gruenke [Allemagne]	THU0400 Inhibition of IL-6 signalling: A novel therapeutic approach for familial mediterranean fever
000429 (2013)	C. Huemer [Autriche, Suisse]	Kindliches Rheuma – juvenile idiopathische Arthritis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "approach" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "approach" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    approach
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021